UPDATE 1-Quidel to buy Diagnostic Hybrids for $130 mln

NEW YORK Jan 10 (Reuters) - Quidel Corp (QDEL.O) said on Sunday it agreed to buy privately held Diagnostic Hybrids Inc for about $130 million in cash, expanding its offerings of diagnostic products to health care providers.

Athens, Ohio-based Diagnostic Hybrids sells diagnostic and analytical products for a range of viral respiratory diseases, herpes virus infections and and other specific viral and thyroid diseases.

Quidel said it plans to operate Diagnostic Hybrids as a separate subsidiary. The deal is expected to close in the first quarter. (Reporting by Paritosh Bansal;Editing by Diane Craft) (For more M&A news and our DealZone blog, go to www.reuters.com/deals)